Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis 由 D V Garbuzenko

獲取全文

Current strategies for targeted therapy of liver fibrosis 由 D. V. Garbuzenko

獲取全文

Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis 由 D. V. Garbuzenko

獲取全文

Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis 由 D V Garbuzenko

獲取全文

The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection 由 D. V. Garbuzenko

獲取全文

Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis 由 D. V. Garbuzenko

獲取全文

Principles of diagnosis and treatment of alcohol-induced liver fibrosis 由 D. V. Garbuzenko

獲取全文

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis 由 D. V. Garbuzenko

獲取全文

Experimental methods of portal hypertension studying 由 D. V. Garbuzenko

獲取全文

Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis 由 D. V. Garbuzenko

獲取全文

Heyde’s syndrome as a rare cause of gastrointestinal bleeding in aortic stenosis patients 由 D. V. Belov, D. V. Garbuzenko, O. P. Lukin, S. S. Anufrieva

獲取全文

Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association 由 V. T. Ivashkin, M. V. Mayevskaya, Ch. S. Pavlov, Ye. A. Fedosyina, Ye. N. Bessonova, I. Yu. Pirogova, D. V. Garbuzenko

獲取全文